This application is a Section 371 of International Application No. PCT/GB2005/000528, filed Feb. 15, 2006, which was published in the English language on Aug. 31, 2006, under International Publication No. WO 2006/090118 A1 and the disclosure of which is incorporated herein by reference.
This invention relates to a safety needle accessory and particularly to a safety needle accessory sealed with in a pack suitable for sealing pre-filled syringes.
Needle stick injuries carry a significant risk of spreading infection such as HIV and hepatitis, and are commonplace among healthcare workers. The USA has led the way in introducing legislation that obliges healthcare providers to use the safest devices when giving injections, intravenous drug administration and similar invasive procedures. Other countries are following, and even without legislation, the ever-present risk of litigation has alerted pharmaceutical companies and health authorities to seek suitable safe devices.
As a result of the heightened awareness of needle stick injuries, there have been a large number of inventions purporting to solve the problem. Most take the form of a protective sleeve which covers the needle tip after the injection has been given, or means for retracting the needle rapidly into the syringe barrel. In the former case, a weakness of the designs has been the need for the user to perform an action to render the needle safe; thus if the step is omitted, the risk remains. In the second case, the needle retraction mechanism requires that the syringe plunger is pushed to the end of its stroke in order to activate the retraction mechanism. In other words, virtually none of the devices are “fail safe”. In many real-life situations, the patient can involuntarily react to the pain of the injection and pull away from the needle, exposing the sharp tip, and therefore presenting a risk of a needle stick.
Another drawback of prior art safety needles (which in the present context includes safety syringes) is that they are not compatible with current accepted practice. The problems includes drug incompatibility with the device construction materials, difficulty in using standard sterilizing methods, difficulty in fitting to the syringe, large size, difficulty in filling, and very high cost.
A common requirement is for pre-filled syringes, and for reasons of drug compatibility and long-term storage, the syringe barrel is often made from glass, with the hypodermic needle bonded into the delivery end of the syringe barrel. Alternatively, a few drugs are compatible with plastics, and there are available plastic syringe barrels with molded or bonded hypodermic needles. Hitherto, there have not been any successful combinations of pre-filled syringe with a bonded-in needle and a safety device to protect the user from suffering a needle-stick injury, and it is to this requirement the present invention is directed. One of the main reasons for the lack of commercial success is that the proposed new devices often include drug contact materials which do not have a safety and compatibility record, or have clumsy operating procedure, are too big, or incompatible with common filling techniques and so forth.
As stated hereinabove, there have been no successful safety needle and pre-filled syringe combinations, and the challenge is to meet the strict requirements of various sterilizing methods, maintaining sterility of the drug and needle during storage, preventing loss of drug through thermal expansion, ease of use, and low cost.
Accordingly, the present invention provides a safety needle accessory comprising a hub for surrounding a hollow needle having a tip and having a connector for attachment to a syringe, a slidable sleeve adapted to slide over the needle in a first longitudinal direction from a first position in which the needle is fully or partially covered by the sleeve to a second position in which the needle is exposed, and in a second longitudinal direction from the second position to a third position in which the needle is fully covered by the sleeve, and a pack surrounding the hollow needle, hub and slidable sleeve having a closed end covering the needle and an open end exposing the connector of the hub, wherein the safety needle accessory further comprises a first seal attached to the connector of the hub and a second seal between the hub and the pack.
The present invention also provides an injection device comprising a syringe having a hollow needle attached thereto and a safety needle accessory as defined herein.
In a first preferred embodiment, a safety device as described in our co-pending patent application WO 2004/071560 is assembled to a syringe (i.e. barrel and plunger) having a bonded hypodermic needle, over which is fitted the safety device. A seal between the syringe and hub of the safety needle accessory is provided by a soft polymer. A pack encloses the syringe and safety device assembly, and has a rubber seal which seals against the periphery of the safety device hub, and further has a rubber seal which seals the opening of the hypodermic needle.
In a second preferred embodiment, which is similar to the first, the seal between the hub of the safety needle accessory and connector also seals directly to the pack, and the hypodermic needle seal is provided as before.
As an alternative to the previous embodiments, in a third embodiment, the safety device is bonded to the outlet connector of a syringe.
The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.
In the drawings:
Unless stated otherwise, like parts are given like notation.
In the present invention, the hub 7 has a hole 14 through which the needle 4 passes with clearance. Hub 7 has an elastic seal 10 which engages sealingly with the connector 2. The connector 2 has a ridge 13 around its circumference, which locally increases the sealing force on the seal 10, and preferably prevents easy removal of the hub 7 and seal 10 from the connector 2. Thus, the elasticity of the seal provides frictional contact between the seal and the other component (here the connector on the syringe) such that a barrier to the ingress of bacteria and pyrogens is created. To achieve low manufacturing cost, the hub 7 may be made from a plastics material, and seal 10 is preferably co-injected molded into the hub 7. This process will ensure bonding of the seal 10 to the hub 7, and thus prevent the passage of harmful bacteria at the junction. Alternatively, and not shown, the seal 10 may be molded as a separate component, and may feature suitable ribs to engage the hub 7. To complete the protection of the drug and needle, a pack 9 is fitted over the safety device/syringe assembly. The pack 9 has an elastic seal 11 which seals onto the rim 15 of seal 10. In addition, a third seal 12 may be located in the closed end of the pack 9, i.e. the end distal to the syringe, and seals the tip of the needle 4. The third seal 12 is typically an elastic seal and sealing is effected by the needle being position such that the tip penetrates the seal 12. The third seal prevents loss or contamination of the injectate. Preferably, the pack 9 has one or more holes 16 sealed by the elastic seal 12, but through which sterilizing gas may permeate. Seal 12 prevents the contents of the syringe 1 from leaking during thermal expansion. The pack 9 is preferably molded in an inexpensive pharmaceutical grade of polyethylene or polypropylene, and the two seals 11 and 12 are preferably co-injection molded to the pack 9. Alternatively, and not shown, both seals 11 and 12 may be made as separate components with the necessary ribs and retaining features to ensure sealing and retention when fitted to the pack 9.
The seal material for the first or second seal 10 and 11 may be low-density polyethylene or a rubber, and the third seal 12 is preferably a pharmaceutical grade of sealing rubber such as iso-butyl rubber. This material is often used because it is a gas-permeable material which permits the passage of a sterilizing gas, such as ethylene oxide, but prevents the passage of harmful bacteria and pyrogens. A common way of bulk packing syringes for pre-filling is to load them into holes in a plastic tray, so that the syringes hang by the finger flange. The loaded tray is placed into a plastic tub, and sealed by a permeable membrane. The sealed tub is subjected to a sterilizing gas such as ethylene oxide, and then, after a period, ordinary atmosphere permeates through the membrane to displace the sterilizing gas, and the membrane prevents the passage of bacteria. During this process, the sterilizing gas also permeates through the rubber seals that protect the needle.
When it is preferable to avoid using ethylene oxide or other sterilizing gas sterilize the assembly, other techniques such as by gamma radiation may be used, and since the sealing materials are not required to be permeable, may be made from other resilient or conformable materials, such as polyester elastomers.
The assembly is shown complete in
Where the accessory is supplied separately from the syringe, the open end of the pack may be covered by a releasable membrane or cap.
The present invention is compatible with current pre-filled syringe technology, including pre-filled reconstitution syringes, whereby a solvent is caused to mix with a lyophilised drug prior to administration.
In all embodiments, when the pack 9 is removed, the safety device remains on the syringe. The present invention is not limited to a precise mechanism of operation of the slidable sleeve. However, the slidable sleeve adapted to slide over the needle in a first longitudinal direction from a first position in which the needle is fully or partially covered by the sleeve to a second position in which the needle is exposed, and in a second longitudinal direction from the second position to a third position in which the needle is fully covered by the sleeve. Preferably the slidable sleeve has an elastically deformable portion 22 and/or further comprises an elastically deformable member 22 such that as the slidable sleeve is caused to move in the first direction towards the second position as the needle is injected into a patient, a resultant force is generated in the deformable portion or deformable member which causes the slidable sleeve to move towards the third (and first) position when the needle is removed from the patient, the safety needle accessory further comprising a locking mechanism 24 capable of retaining the slidable sleeve in the third position after removal of the needle from the patient. The accessory may also further comprise engageable portions 26 on the slidable sleeve and the hub to hold the sleeve in the first position where the sleeve is partially retracted and, when assembled with a syringe having a hollow needle, the needle is partially exposed. This allows the tip of the needle to be seen by the user prior to injection. This assists the user in guiding the needle for placement on the patient's skin or aspirating excess drug or air. Preferably the injection device of the present invention is supplied prior to use with the needle tip partially exposed. The pack is then removed and the needle injected into the patient. Further details are described in WO 2004/071560. Other safety devices intended to prevent or reduce needle-stick injuries, and which may employ a resiliently biased sliding sleeve (see, for example U.S. Pat. No. 4,813,940 and U.S. Pat. No. 5,104,384) may also be used with the accessory of the present invention.
It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
Number | Date | Country | Kind |
---|---|---|---|
0504130.6 | Feb 2005 | GB | national |
0506431.6 | Mar 2005 | GB | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB2006/000528 | 2/15/2006 | WO | 00 | 9/14/2007 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2006/090118 | 8/31/2006 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1845036 | Busher | Feb 1932 | A |
2677373 | Barradas | May 1954 | A |
3114455 | Claisse et al. | Dec 1963 | A |
3134380 | Armao | May 1964 | A |
3677245 | Welch | Jul 1972 | A |
4553541 | Burns | Nov 1985 | A |
4564054 | Gustavsson | Jan 1986 | A |
4664654 | Strauss | May 1987 | A |
4735203 | Ryder et al. | Apr 1988 | A |
4795432 | Karczmer | Jan 1989 | A |
4813940 | Parry | Mar 1989 | A |
4850996 | Cree | Jul 1989 | A |
4892521 | Laico et al. | Jan 1990 | A |
4911693 | Paris | Mar 1990 | A |
4927019 | Haber et al. | May 1990 | A |
5015240 | Soproni et al. | May 1991 | A |
5051109 | Simon | Sep 1991 | A |
5104384 | Parry | Apr 1992 | A |
5219339 | Saito | Jun 1993 | A |
5242401 | Colsky | Sep 1993 | A |
5273539 | Chen | Dec 1993 | A |
5312366 | Vailancourt | May 1994 | A |
5336197 | Kuracina et al. | Aug 1994 | A |
5385561 | Cerny | Jan 1995 | A |
5421347 | Enstrom | Jun 1995 | A |
5549568 | Shields | Aug 1996 | A |
5562624 | Righi | Oct 1996 | A |
5601535 | Byrne et al. | Feb 1997 | A |
5645530 | Boukhny et al. | Jul 1997 | A |
5658256 | Shields | Aug 1997 | A |
5669888 | Trapp | Sep 1997 | A |
5755696 | Caizza | May 1998 | A |
5810784 | Tamaro | Sep 1998 | A |
5891103 | Burns | Apr 1999 | A |
5893842 | Imbert | Apr 1999 | A |
5894015 | Rechtin | Apr 1999 | A |
5910130 | Caizza et al. | Jun 1999 | A |
5944699 | Barrelle et al. | Aug 1999 | A |
5971966 | Lav | Oct 1999 | A |
6203529 | Gabriel et al. | Mar 2001 | B1 |
6210374 | Malencheck | Apr 2001 | B1 |
6261264 | Tamaro | Jul 2001 | B1 |
6331174 | Reinhard et al. | Dec 2001 | B1 |
6398762 | Vetter et al. | Jun 2002 | B1 |
6511460 | Arnissolle | Jan 2003 | B1 |
6537259 | Niermann | Mar 2003 | B1 |
6565541 | Sharp | May 2003 | B2 |
6685676 | Jansen et al. | Feb 2004 | B2 |
7041086 | Yang | May 2006 | B2 |
7182734 | Saulenas et al. | Feb 2007 | B2 |
7223258 | Crawford | May 2007 | B2 |
7713280 | Marshall et al. | May 2010 | B2 |
8105293 | Pickhard | Jan 2012 | B2 |
8425468 | Weston | Apr 2013 | B2 |
8979802 | Woehr | Mar 2015 | B2 |
20020004648 | Larsen et al. | Jan 2002 | A1 |
20020087180 | Searle et al. | Jul 2002 | A1 |
20030014018 | Giambattista et al. | Jan 2003 | A1 |
20030144633 | Kirchhofer | Jul 2003 | A1 |
20040049160 | Hsieh et al. | Mar 2004 | A1 |
20040082911 | Tiu et al. | Apr 2004 | A1 |
20040116877 | Yang | Jun 2004 | A1 |
20040210196 | Bush Jr. | Oct 2004 | A1 |
20050038391 | Wittland | Feb 2005 | A1 |
20060129173 | Wilkinson | Jun 2006 | A1 |
20060167411 | Weston et al. | Jul 2006 | A1 |
20080183140 | Paproski et al. | Jul 2008 | A1 |
20080215013 | Felix-Faure | Sep 2008 | A1 |
20090012478 | Weston | Jan 2009 | A1 |
20100076382 | Weston | Mar 2010 | A1 |
20130190693 | Ekman et al. | Jul 2013 | A1 |
Number | Date | Country |
---|---|---|
1777453 | May 2006 | CN |
0467173 | Jan 1992 | EP |
0744183 | Nov 1996 | EP |
0815884 | Jan 1998 | EP |
1252907 | Oct 2002 | EP |
1447108 | Aug 2004 | EP |
1535640 | Jun 2005 | EP |
1558311 | Aug 2005 | EP |
2701848 | Sep 1994 | FR |
3158171 | Jul 1991 | JP |
9111212 | Aug 1991 | WO |
WO 9400172 | Jan 1994 | WO |
9419036 | Sep 1994 | WO |
0176665 | Oct 2001 | WO |
0191837 | Dec 2001 | WO |
02089878 | Nov 2002 | WO |
02100467 | Dec 2002 | WO |
03066141 | Aug 2003 | WO |
2004000397 | Dec 2003 | WO |
2004071560 | Aug 2004 | WO |
2004069302 | Aug 2004 | WO |
2006082350 | Aug 2006 | WO |
2006090118 | Aug 2006 | WO |
2008067467 | Jun 2008 | WO |
Entry |
---|
“seal.” Merriam-Webster.com. Merriam-Webster, 2011.Web. Jul. 21, 2011. |
Definition of ‘Contact’ —Collins English Dictionary. Accessed online Jan. 15, 2014. |
Chinese Office Action for the corresponding Chinese Patent Application No. 200680006138.6; dated Jun. 5, 2009; 8 pages (including English translation). |
European Search Report issued on Oct. 4, 2010 in European Patent Application No. EP 09 17 5295. |
Office Action issued Dec. 7, 2010 in U.S. Appl. No. 12/470,220. |
Australian Examination Report for the related Australian Application No. 2004212245 dated Nov. 11, 2008. |
Chinese Office Action for the related Chinese Application No. 200480006925.1 dated Feb. 20, 2009. |
Chinese Office Action for the related Chinese Application No. 200480006925.1 dated Jul. 10, 2009. |
Chinese Office Action for the related Chinese Application No. 200480006925.1 dated Dec. 28, 2007. |
Chinese Office Action for the related Chinese Application No. 2005800477077 dated Sep. 25, 2009. |
Chinese Office Action for the related Chinese Application No. 200680006138.6 dated Dec. 11, 2009. |
European Search Report for the related European Application No. 03 25 7489 dated May 25, 2004. |
European Search Report for the related European Application No. 03 25 2192 dated May 26, 2003. |
U.K. Search Report for the related U.K. Application No. 0621157.7 dated Jan. 25, 2007. |
International Search Report and Written Opinion for the related International Application No. PCT/GB2005/000357 dated Aug. 26, 2005. |
International Search Report and Written Opinion for the related International Application No. PCT/US2007/017455 dated Nov. 19, 2007. |
International Search Report and Written Opinion for the related International Application No. PCT/GB2004/000516 dated May 27, 2004. |
Japanese Office Action for the related Japanese Application No. 2006-502257 dated Sep. 11, 2009. |
Japanese Office Action for the related Japanese Application No. 2006-502257 dated Jan. 15, 2010. |
Office Action for the related U.S. Appl. No. 10/545,160, dated Mar. 3, 2010. |
Office Action for the related U.S. Appl. No. 11/815,475, dated Oct. 1, 2008. |
Office Action for the related U.S. Appl. No. 11/815,475, dated Jan. 4, 2010. |
Office Action for the related U.S. Appl. No. 11/815,475, dated Apr. 9, 2009. |
Office Action for the related U.S. Appl. No. 10/545,160, dated Aug. 18, 2009. |
Office Action for the related U.S. Appl. No. 11/815,475, dated Aug. 21, 2009. |
International Search Report and Written Opinion for the related International Application No. PCT/US2008/077352 mailed Jan. 30, 2009. |
Partial European Search Report for the related European Application No. 09175295.6 dated Apr. 9, 2010. |
Chinese Office Action for the related Chinese Application No. 200680006138.6 dated Apr. 15, 2010. |
International Preliminary Report on Patentability for the related International Application No. PCT1US20081077352 dated Apr. 13, 2010. |
Office Action issued Jul. 30, 2010 in Chinese Application No. 20068006138.6. |
Office Action Issued Sep. 7, 2010 in Japanese Patent Application No. 2007-553675. |
Office Action Issued Oct. 6, 2011 in U.S. Appl. No. 10/545,160. |
Office Action Issued Apr. 29, 2011 in U.S. Appl. No. 12/276,679. |
Office Action Issued May 6, 2011 in U.S. Appl. No. 12/470,220. |
Office Action issued Apr. 26, 2011 in JP Application No. 2007-556647. |
Office Action issued Jun. 17, 2011 in U.S. Appl. No. 12/680,811. |
Office Action issued Sep. 23, 2011 in CN Application No. 200880110889.1. |
Office Action issued Dec. 23, 2011 in U.S Appl. No. 12/276,679. |
Office Action issued Jan. 5, 2012 in U.S Appl. No. 121680,811. |
Witness statement of T. E. Weston (inventor), Aug. 27, 2010. |
Second witness statement of T. E. Weston (inventor), Mar. 24, 2011. |
Third witness statement of T. E. Weston (inventor), Jan. 5, 2012. |
Witness statement of John Davison, May 3, 2011. |
Statement from claimant in UK revocation proceeding regarding EP Patent No. 1558311, Jul. 15, 2010. |
Defendant's counter-statement in UK revocation proceeding regarding EP Patent No. 1558311, Aug. 31, 2010. |
Defendant's supplementary counter-statement in UK revocation proceeding regarding EP Patent No. 1558311, Mar. 25, 2011. |
Written Preliminary Evaluation in UK revocation proceeding regarding EP Patent No. 1558311, Nov. 10, 2011. |
Witness statement of Barry Peter Liversidge on behalf of tip-top.com Ltd. in UK revocation proceeding regarding EP Patent No. 1558311, Jan. 19, 2012. |
Defendant's further counter-statement in UK revocation proceeding regarding EP Patent No. 1558311, Jan. 17, 2012. |
Defendant's consolidated counter-statement in UK revocation proceeding regarding EP Patent No. 1558311, Mar. 9, 2012. |
Office Action issued Aug. 1, 2012 in U.S. Appl. No. 12/680,811. |
Office Action issued Dec. 5, 2012 in U.S. Appl. No. 12/276,679. |
Office Action issued Jan. 16, 2014 in U.S. Appl. No. 12/470,220, by Emmott. |
Number | Date | Country | |
---|---|---|---|
20080167624 A1 | Jul 2008 | US |